Integer (NYSE:ITGR) Hits New 52-Week High – What’s Next?

Integer Holdings Co. (NYSE:ITGRGet Free Report)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $144.22 and last traded at $143.22, with a volume of 5118 shares changing hands. The stock had previously closed at $141.00.

Analyst Ratings Changes

A number of brokerages have issued reports on ITGR. Truist Financial raised their price target on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Piper Sandler reissued an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Bank of America boosted their target price on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Benchmark increased their price target on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. Finally, Citigroup upped their price objective on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, Integer currently has an average rating of “Moderate Buy” and an average target price of $145.44.

Read Our Latest Stock Report on Integer

Integer Trading Up 1.0 %

The firm has a fifty day moving average of $136.56 and a 200-day moving average of $129.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The stock has a market capitalization of $4.78 billion, a price-to-earnings ratio of 43.96, a P/E/G ratio of 1.80 and a beta of 1.12.

Integer (NYSE:ITGRGet Free Report) last announced its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. The business had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company’s revenue was up 8.7% on a year-over-year basis. During the same period last year, the business posted $1.27 EPS. As a group, equities analysts predict that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Integer

Institutional investors have recently added to or reduced their stakes in the company. Contravisory Investment Management Inc. lifted its stake in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 80 shares in the last quarter. Huntington National Bank increased its holdings in Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 268 shares during the last quarter. Versant Capital Management Inc raised its position in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after purchasing an additional 183 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Integer by 74.1% during the 3rd quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 278 shares during the last quarter. Finally, Larson Financial Group LLC grew its position in shares of Integer by 20,000.0% during the third quarter. Larson Financial Group LLC now owns 1,005 shares of the medical equipment provider’s stock worth $131,000 after buying an additional 1,000 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

(Get Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Recommended Stories

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.